Cytokinetics (CYTK) PT Raised to $65 at Cantor Fitzgerald
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $76.10 +0.30%
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Rating Summary:
23 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 16 | New: 37
Join SI Premium – FREE
Cantor Fitzgerald analyst Charles Duncan raised the price target on Cytokinetics (NASDAQ: CYTK) to $65.00 (from $59.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Outlook Therapeutics Inc. (OTLK) PT Lowered to $4 at Brookline Capital Markets
- H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
